Patient
SITE015-0102
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE015 (POL) (Dr. Ito)
consented 2025-12-24
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-09-14 (study day 68); relationship: not assessed
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-08-15 (study day 38); relationship: not assessed
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-08-12 (study day 35); relationship: not assessed
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-08-11 (study day 34); relationship: not assessed
Grade 3 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-30 (study day 22); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.